Search Results - "Panzenbeck, Mark"
-
1
Deep learning for discovering pathological continuum of crypts and evaluating therapeutic effects: An implication for in vivo preclinical study
Published in PloS one (14-06-2021)“…Applying deep learning to the field of preclinical in vivo studies is a new and exciting prospect with the potential to unlock decades worth of underutilized…”
Get full text
Journal Article -
2
An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
Published in Frontiers in immunology (22-10-2018)“…Despite the negative results of blocking IL-17 in Crohn's disease (CD) patients, selective modulation of Th17-dependent responses warrants further study…”
Get full text
Journal Article -
3
Nonsteroidal Dissociated Glucocorticoid Agonists Containing Azaindoles as Steroid A-Ring Mimetics
Published in Journal of medicinal chemistry (23-09-2010)“…Syntheses and structure−activity relationships (SAR) of nonsteroidal glucocorticoid receptor (GR) agonists are described. These compounds contain azaindole…”
Get full text
Journal Article -
4
CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells
Published in PloS one (29-08-2014)“…Inflammation is associated with immune cells infiltrating into the inflammatory site and pain. CC chemokine receptor 1 (CCR1) mediates trafficking of…”
Get full text
Journal Article -
5
Indole Inhibitors of MMP-13 for Arthritic Disorders
Published in ACS omega (27-07-2021)“…Here, we described the design, by fragment merging and multiparameter optimization, of selective MMP-13 inhibitors that display an appropriate balance of…”
Get full text
Journal Article -
6
Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores
Published in Bioorganic & medicinal chemistry letters (15-11-2011)“…We report a SAR of non-steroidal glucocorticoid mimetics that utilize indoles as A-ring mimetics. A detailed SAR is discussed with a focus on improving PR and…”
Get full text
Journal Article -
7
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease
Published in American journal of physiology: Gastrointestinal and liver physiology (01-11-2021)“…Mouse and human data implicate the NOD1 and NOD2 sensors of the intestinal microbiome and the associated signal transduction via the receptor interacting…”
Get more information
Journal Article -
8
BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis
Published in Clinical immunology (Orlando, Fla.) (01-12-2018)“…Lupus nephritis is a common disease manifestation of SLE, in which immune complex deposition and macrophage activation are important contributors to disease…”
Get full text
Journal Article -
9
-
10
Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357
Published in ACS medicinal chemistry letters (14-01-2021)“…The interleukin (IL)-23/T helper (Th)17 axis plays a critical role in autoimmune diseases, and there is an increasing number of biologic therapies that target…”
Get full text
Journal Article -
11
Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers
Published in Crohn's & colitis 360 (01-01-2020)“…Short non-coding microRNAs (miRNAs) are involved in various cellular processes during disease progression of Crohn's disease (CD) and remarkably stable in…”
Get full text
Journal Article -
12
Identification and characterization of an antagonistic anti-mouse CD40 antibody
Published in The Journal of immunology (1950) (01-05-2016)“…Abstract Targeting CD40-CD40L interactions has been an interesting drug concept for the treatment of autoimmune diseases given this pathway’s role in the…”
Get full text
Journal Article -
13
BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells
Published in The Journal of pharmacology and experimental therapeutics (01-06-2016)“…BI 1002494 [(R)-4-{(R)-1-[7-(3,4,5-trimethoxy-phenyl)-[1,6]napthyridin-5-yloxy]-ethyl}pyrrolidin-2-one] is a novel, potent, and selective spleen tyrosine…”
Get more information
Journal Article -
14
An RORγt oral inhibitor modulates IL-17 responses in peripheral blood and intestinal mucosa of Crohn's disease patients
Published in Frontiers in immunology (22-10-2018)“…Background and Aims: Despite the negative results of blocking IL-17 in Crohn's disease (CD) patients, selective modulation of Th17-dependent responses warrants…”
Get full text
Journal Article -
15
An RORγt oral inhibitor modulates IL-17 responses in peripheral blood and intestinal mucosa of Crohn's disease patients
Published in Frontiers in immunology (22-10-2018)“…Background and Aims: Despite the negative results of blocking IL-17 in Crohn's disease (CD) patients, selective modulation of Th17-dependent responses warrants…”
Get full text
Journal Article -
16
Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore
Published in Bioorganic & medicinal chemistry letters (15-04-2014)“…Synthesis and structure-activity relationship (SAR) of a series of alkyl and cycloalkyl containing non-steroidal dissociated glucocorticoid receptor (GR)…”
Get full text
Journal Article -
17
The oxidase activity of vascular adhesion protein-1 (VAP-1) is essential for function
Published in American journal of clinical and experimental immunology (01-01-2013)“…Vascular adhesion protein-1 (VAP-1) has been implicated in the pathogenesis of inflammatory diseases and is suggested to play a role in immune cell…”
Get full text
Journal Article